Study of sentinel node biopsy with methylene blue and patent blue violet injection in patients with breast cancer
- VernacularTitle:美蓝和专利蓝在乳癌前哨淋巴结活检中作用的研究
- Author:
Jianjun HE
;
Yu REN
;
Wuke CHEN
;
Hong REN
;
Chengxue DANG
;
Dongmin CHANG
- Publication Type:Journal Article
- Keywords:
BREAST NEOPLASMS/pathol;
?LYMPHATIC METASTASIS;
?STAINS AND STAINING;
?BIOPSY
- From:
Chinese Journal of General Surgery
1994;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the identification rate of sentinel lymph node (SLN) in patients with breast cancer (BC) and the accuracy in predicting axillary lymph node(ALN) metastasis using methylene blue (MB) and patent blue violet (PBV) injection. Methods From October, 1999 to April, 2001, 94 patients with BC were selected for this study. Of them, 32 patients were injected with 1% MB and 62 patients with 1% PBV to identify SLN. All 94 patients underwent the axillary lymph node dissection. Results In MB group and PBV group , the SLN identification rate were 65.6% (21/32), 88.7% (55/62); the accuracy rate to predict axillary lymph node status were 90.5% (19/21), 98.2% (54/55) respectively. Conclusion Compared with MB ,PVB is the more ideal vital blue dye in identification of SNB.
